Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Defining rewardable innovation in drug therapy.

Literature DB >> 22460109

Defining rewardable innovation in drug therapy.

Jeffrey K Aronson¹, Robin E Ferner, Dyfrig A Hughes.

Abstract

Implementing mechanisms for rewarding those who introduce innovative medicinal products requires a definition of 'rewardable innovation'. Here, we propose a definition of innovation with respect to medicinal products, accompanied by a ranking of the importance of different types of innovativeness, with the aim of providing a basis for rewarding such innovation.

Mesh：

Year: 2012 PMID： 22460109 DOI： 10.1038/nrd3715

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

3 in total

1. Something new every day: defining innovation and innovativeness in drug therapy.

Authors: Jeffrey K Aronson
Journal: J Ambul Care Manage Date: 2008 Jan-Mar

2. NICE and new: appraising innovation.

Authors: Robin E Ferner; Dyfrig A Hughes; Jeffrey K Aronson
Journal: BMJ Date: 2010-01-05

3. Value-based pricing: incentive for innovation or zero net benefit?

Authors: Dyfrig A Hughes
Journal: Pharmacoeconomics Date: 2011-09 Impact factor: 4.981

3 in total

11 in total

1. Innovation and value-driven engineering.

Authors: Frank L Douglas
Journal: Nat Rev Drug Discov Date: 2012-04-30 Impact factor: 84.694

2. Innovation in orthopaedic surgery as it relates to evidence-based practice.

Authors: M Hofbauer; B Muller; C D Murawski; J Karlsson; Freddie H Fu
Journal: Knee Surg Sports Traumatol Arthrosc Date: 2013-03 Impact factor: 4.342

3. Do the EMA accelerated assessment procedure and the FDA priority review ensure a therapeutic added value? 2006-2015: a cohort study.

Authors: Denis Boucaud-Maitre; Jean-Jacques Altman
Journal: Eur J Clin Pharmacol Date: 2016-07-29 Impact factor: 2.953

4. Using GRADE methodology to assess innovation of new medicinal products in Italy.

Authors: Filomena Fortinguerra; Giovanni Tafuri; Francesco Trotta; Antonio Addis
Journal: Br J Clin Pharmacol Date: 2019-11-21 Impact factor: 4.335

5. Patterns and predictors of physician adoption of new cardiovascular drugs.

Authors: Timothy S Anderson; Wei-Hsuan Lo-Ciganic; Walid F Gellad; Rouxin Zhang; Haiden A Huskamp; Niteesh K Choudhry; Chung-Chou H Chang; Seth Richards-Shubik; Hasan Guclu; Bobby Jones; Julie M Donohue
Journal: Healthc (Amst) Date: 2017-10-21

Review 6. The most transformative drugs of the past 25 years: a survey of physicians.

Authors: Aaron S Kesselheim; Jerry Avorn
Journal: Nat Rev Drug Discov Date: 2013-05-17 Impact factor: 84.694

7. How innovative are new drugs launched in the UK? A retrospective study of new drugs listed in the British National Formulary (BNF) 2001-2012.

Authors: Derek J Ward; Angharad Slade; Tracey Genus; Orsolina I Martino; Andrew J Stevens
Journal: BMJ Open Date: 2014-10-24 Impact factor: 2.692

Review 8. Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.

Authors: Patricia Vella Bonanno; Michael Ermisch; Brian Godman; Antony P Martin; Jesper Van Den Bergh; Liudmila Bezmelnitsyna; Anna Bucsics; Francis Arickx; Alexander Bybau; Tomasz Bochenek; Marc van de Casteele; Eduardo Diogene; Irene Eriksson; Jurij Fürst; Mohamed Gad; Ieva Greičiūtė-Kuprijanov; Martin van der Graaff; Jolanta Gulbinovic; Jan Jones; Roberta Joppi; Marija Kalaba; Ott Laius; Irene Langner; Ileana Mardare; Vanda Markovic-Pekovic; Einar Magnusson; Oyvind Melien; Dmitry O Meshkov; Guenka I Petrova; Gisbert Selke; Catherine Sermet; Steven Simoens; Ad Schuurman; Ricardo Ramos; Jorge Rodrigues; Corinne Zara; Eva Zebedin-Brandl; Alan Haycox
Journal: Front Pharmacol Date: 2017-08-23 Impact factor: 5.810

9. Trends in the costs of drugs launched in the UK between 1981 and 2015: an analysis of the launch price of drugs in five disease areas.

Authors: Derek J Ward; Lucy Doos; Andrew Stevens
Journal: BMJ Open Date: 2019-05-05 Impact factor: 2.692

Review 10. Me-too pharmaceutical products: History, definitions, examples, and relevance to drug shortages and essential medicines lists.

Authors: Jeffrey K Aronson; A Richard Green
Journal: Br J Clin Pharmacol Date: 2020-05-13 Impact factor: 4.335